Cullinan Therapeutics
CGEM
#6219
Rank
A$1.07 B
Marketcap
$18.53
Share price
5.94%
Change (1 day)
33.35%
Change (1 year)

Cullinan Therapeutics (CGEM) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$40.55 Million

According to Cullinan Therapeutics's latest financial reports the company's total liabilities are A$40.55 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cullinan Therapeutics - Total liabilities on balance sheet (from 2019 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$44.45 M15.96%
2022-12-31A$38.33 M135.32%
2021-12-31A$16.29 M-12.97%
2020-12-31A$18.71 M-90.66%
2019-12-31A$0.20 B155.45%
2018-12-31A$78.48 M